PHARMACEUTICAL MANUFACTURING

CONTRACT PHARMA MANUFACTURING WHITE PAPERS & ARTICLES

  • Single-Vendor CDMOs Bring Speed And Cost Savings To The Table

    A single vendor offers access to a network of experts across several disciplines who can share knowledge about a project as it moves from phase to phase, thus helping to navigate its path toward commercial success. Following a CPhI North America panel about single-source CDMOs, Paul Nelson, vice president of supply chain and R&D at Amring Pharmaceuticals, discusses his experience with single-source CDMOs.

  • How To Rapidly Create Single-Use Biomanufacturing Capacity

    To meet therapy production demands, the industry needs to have the right capacity, in the right locations. Increasingly, single-use technologies are being seen as flexible and cost-effective solutions.

  • Consultants’ Guide To Flexible Biomanufacturing Solutions

    Consultants play a critical role in ensuring the long-term success of small biopharmaceutical companies, though much of their work happens behind the scenes. From lifecycle planning to marketing advice, consultants help fill gaps in knowledge while having their fingers on the pulse of new production strategies that might be a fit for clients.

  • What Value Can An Integrated Solution Bring To Your Biopharma Outsourcing Strategy?

    The growth in outsourcing is one strategy life science innovators are pursuing to address the evolving pharma landscape; however, should a sponsor company seek the traditional route of utilizing multiple partners across the supply chain or does an integrated CDMO offer a more efficient and faster path to commercialization?

  • Accelerate Biopharmaceutical Development With Novel Analytical Techniques

    This article explains how using an Octet-based Fc receptor panel may help developers achieve a faster assessment of monoclonal antibody functionality, well before the final molecule is selected.

  • End-to-end Technology Transfer Services In Oral Solids And Sterile

    In the pharmaceutical industry, “technology transfer” refers to the processes that are needed for successful progression of stages ranging from drug discovery, product development, clinical trials to full-scale commercialization or it is the transfer between development and commercialization at different sites within or outside an organization.

  • The Upswing Of Sterile Injectables

    The $330 bn global sterile market is expected to reach $525 bn by 2020, growing at a CAGR of 11% -with North America contributing 48% while APAC is expected to record highest CAGR of 13%.

More From Pharmaceutical Manufacturing White Papers & Articles

CONTRACT PHARMA MANUFACTURING APPLICATIONS & STUDIES

  • Versatility Of Softgel Technology: The Encapsulation Of A Volatile Compound
    Versatility Of Softgel Technology: The Encapsulation Of A Volatile Compound

    A commercial stage medical technology company has developed SMART Softgels featuring a special shell to release quickly while still preventing evaporative loss during and after manufacturing. 

  • Paediatric Drug Product Development Through To Commercialization
    Paediatric Drug Product Development Through To Commercialization

    Almac has developed a flexible paediatric dosage form consisting of minitablets filled into stickpacks using a robust manufacturing and filling process suitable for routine commercial manufacture.

  • Accelerated Fill/Finish CGMP Campaign For A Biologic Drug Product Program
    Accelerated Fill/Finish CGMP Campaign For A Biologic Drug Product Program

    Manufacturing of biological and small molecule drug products is on the rise, and more often than not, generation of stability data and getting product released for clinical trials are on the critical path to approval. Emergent Camden not only understands that, but delivers quality product in timelines significantly shorter than other contract manufacturers.

  • Case Study: Controlled Drug Handling A midsize pharmaceutical company came to Aptuit to work through the complexities of exporting a controlled substance manufactured in the United States and an EU-sourced comparator for inclusion in a clinical trial across more than 12 EU participating countries. Aptuit’s client was dealing with an Investigative Medicinal Product (IMP) manufactured in the United States and an EU-sourced comparator. By Aptuit, Inc.
More From Pharmaceutical Manufacturing Applications & Studies

CONTRACT PHARMA MANUFACTURING SERVICES

API Development & Manufacturing Services API Development & Manufacturing Services

Piramal Pharma Solutions is the contract development and manufacturing (CDMO) arm of Piramal Enterprises Ltd. with a vast network of development and manufacturing facilities in North America,Europe and Asia.

Aseptic Fill/Finish Commerical Contract Manufacturing Aseptic Fill/Finish Commerical Contract Manufacturing

Emergent BioSolutions currently fills over 20 commercial products with several more products pending approval. Using Emergent BioSolutions for commercial manufacturing has a number of advantages.

Drug Product CGMP Lyophilization Manufacturing Services Drug Product CGMP Lyophilization Manufacturing Services

Emergent BioSolutions currently fills a number of lyophilized products in its two 240 ft2 lyophilizers.

Clinical Contract Manufacturing Clinical Contract Manufacturing

Emergent BioSolutions performs clinical manufacturing for all regulatory phases. Contracting with Emergent BioSolutions or clinical manufacturing has a number of advantages.

Fill/Finish Product Testing & Stability Testing Fill/Finish Product Testing & Stability Testing

Emergent BioSolutions typically performs the following testing on products.

Contract Development And Manufacturing (CDMO) Formulation Services Contract Development And Manufacturing (CDMO) Formulation Services

Piramal Pharma Solutions is the contract development and manufacturing (CDMO) arm of Piramal Enterprises Ltd., having a vast network of development and manufacturing facilities located in North America, Europe and Asia.

CDMO For All Phases Of The Drug Life Cycle CDMO For All Phases Of The Drug Life Cycle

Piramal Pharma Solutions is the contract development and manufacturing (CDMO) arm of Piramal Enterprises Ltd with a vast network of development and manufacturing facilities located in North America, Europe and Asia. 

High Potency API (HPAPI) Development & Manufacturing High Potency API (HPAPI) Development & Manufacturing

Piramal Pharma Solutions (PPS) is pleased to welcome Ash Stevens LLC as a part of the Piramal Group. Leveraging five decades of Ash Stevens’s operational experience and technical expertise, Piramal’s service offering now includes High Potency API (HPAPI) development and manufacturing capabilities. Located in Riverview, USA, our state-of the-art FDA licensed cGMP facility offers a full range of scale and containment options for high potency API manufacturing.

Pharmaceutical Contract Packaging: Quality And Technologies Pharmaceutical Contract Packaging: Quality And Technologies

Our cutting-edge technology and impeccable standards ensure that our customers receive products that meet their exact needs.

More From Pharmaceutical Manufacturing Services

 PHARMACEUTICAL MANUFACTURING EVENTS

Clinical Study Requirements – Understanding Differences Between the US and EU July 25, 2017
1pm-2:30pm EST, Online Training
Price:  $299 - Includes Bonus Handouts!
Simplifying Your Quality System While Implementing ISO 13485:2016 Requirements – Strategies for Success July 27, 2017
1pm-2:30pm EDT, Online Training
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
Drug Development 101 – How A Drug Is Made August 3, 2017
1pm-2:30pm EDT, Online Training
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
ICH E6 Addendum R2 Team Training and Action Planning August 7, 2017
11:00am- 12:00pm EDT, Online Training
Duration:  60 Minutes
Price:  $299 - Includes Bonus Handouts!
Cell Therapy: Process Design Considerations To Support Commercialization August 9, 2017
1pm-2:30pm EDT, Online Training
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!